SPOROS BIOVENTURES
Sporos Bioventures is a biotechnology firm that focuses on oncology, fibrosis, inflammation, and autoimmune and infection therapeutics. For patients with cancer and immune diseases, Sporos is transforming knowledge into a new hope. Sporos' team of accomplished leaders identifies novel disease mechanisms and catalyzes the development of breakthrough medicines by leveraging our extensive network, strategic resources, and operational expertise.
SPOROS BIOVENTURES
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Status:
Active
Total Funding:
38.1 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Sitelinks Search Box Yoast WordPress SEO Plugin Yoast Plugins Yoast SEO Premium
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-15 | Tvardi Therapeutics | Sporos Bioventures investment in Series B - Tvardi Therapeutics | 72.42 M USD |
| 2021-06-03 | Stellanova Therapeutics | Sporos Bioventures investment in Series A - Stellanova Therapeutics | 15.5 M USD |
| 2021-05-25 | Asylia Therapeutics | Sporos Bioventures investment in Series A - Asylia Therapeutics | 14.5 M USD |
| 2021-01-26 | Nirogy Therapeutics | Sporos Bioventures investment in Series A - Nirogy Therapeutics | 16.5 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-29 | Sporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive Officer |
More informations about "Sporos Bioventures"
Developing Targeted Cancer Treatments | Sporos …
Sporos Bioventures, LLC is a private biotechnology company focused on transforming the drug development process across oncology through its portfolio approach. Sporos Bioventures owns equity interests in several biopharma …See details»
Sporos Bioventures - LinkedIn
Sporos Bioventures is a private biopharmaceutical company that aims to transform the drug development process by focusing on key mechanisms and targets of disease to accelerate drug discovery ...See details»
Sporos Bioventures | VentureRadar
Sporos identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough medicines. Its current …See details»
Sporos Bioventures - Funding, Financials, Valuation & Investors
Sporos Bioventures is a biotechnology firm that aims to catalyze the rapid and accurate development of cancer and immune disease treatments.See details»
Sporos Bioventures Announces Formation of Strategic …
Jan 11, 2022 Sporos Bioventures, LLC, (“Sporos” or the “Company”) a private biotechnology company catalyzing the rapid development of potential breakthrough therapSee details»
Sporos Bioventures Raises $38.1 Million in Series A Financing
May 17, 2021 Sporos Bioventures made its launch official with the close of a $38.1 million Series A financing. FREMONT, CA: Sporos Bioventures, LLC (the Company or Sporos) made its …See details»
SPOROS BIOVENTURES, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SPOROS BIOVENTURES, INC. of Houston, TX. Get the latest business insights from Dun & Bradstreet.See details»
News & Events - Sporos Bioventures
May 6, 2021 Sporos Launches with $38.1 Million Series A Financing May 6, 2021 | Press Releases Company intends to develop and extend its diverse pipeline of therapies for cancer …See details»
Sporos Bioventures - Crunchbase
Sporos Bioventures is a biotechnology firm that aims to catalyze the rapid and accurate development of cancer and immune disease treatments.See details»
Sporos Bioventures Appoints Dr. Rachel Humphrey to …
Jan 4, 2022 Sporos Bioventures, LLC (“Sporos” or the “Company”), a private biotechnology company catalyzing the rapid development of breakthrough therapies througSee details»
Houston-based cancer and disease bio-venture launches after ...
May 13, 2021 Sporos Bioventures LLC launched this month after closing a $38.1 million round of series A financing. The Houston-based biotech company aims to accelerate the development …See details»
Biotech incubator Sporos' new CEO arrives from Ovid with Biogen ...
Sep 29, 2021 His next stop is leading Houston biotech incubator Sporos Bioventures. Rakhit hit the exit at Ovid as president and chief medical officer after the biotech's lead therapy failed a …See details»
Sporos Bioventures Announces Formation of Strategic Advisory …
HOUSTON, Texas., January 11, 2022 — Sporos Bioventures, LLC, (“Sporos” or the “Company”) a private biotechnology company catalyzing the rapid development of potential breakthrough …See details»
Sporos Bioventures Announces Formation of Strategic Advisory …
Jan 11, 2022 HOUSTON-- ( BUSINESS WIRE )-- Sporos Bioventures, LLC, (“Sporos” or the “Company”) a private biotechnology company catalyzing the rapid development of potential …See details»
Sporos Bioventures leads a group of four entities with a $38.1M …
May 6, 2021 Sporos Bioventures LLC closed a $38.1 million series A financing to develop a pipeline of therapies for treating cancer and immune diseases through four companies with a …See details»
News & Events - Sporos Bioventures
Sporos BioDiscovery is a wholly-owned affiliate company of Sporos Bioventures, LLC, a private biotechnology company focused on transforming the drug development process across oncology.See details»
Sporos Bioventures Raises $38.1M in Series A Financing
May 6, 2021 Sporos Bioventures, LLC, a Houston, TX-based company formed to catalyze the development of therapies that target novel disease mechanisms in cancer and immune …See details»
Sporos Launches with $38.1 Million Series A Financing
HOUSTON, May 06, 2021 (GLOBE NEWSWIRE) -- Sporos Bioventures, LLC (the “Company” or “Sporos”), officially launched today with the close of a $38.1 million Series A financing. The …See details»